SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001564590-21-016109
Filing Date
2021-03-29
Accepted
2021-03-29 16:01:16
Documents
13
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A alec-10ka_20201231.htm 10-K/A 184282
2 EX-31.1 alec-ex311_7.htm EX-31.1 18764
3 EX-31.2 alec-ex312_6.htm EX-31.2 18770
  Complete submission text file 0001564590-21-016109.txt   379687

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT alec-20201231.xml EX-101.INS 8582
5 XBRL TAXONOMY EXTENSION SCHEMA alec-20201231.xsd EX-101.SCH 5772
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE alec-20201231_lab.xml EX-101.LAB 30010
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alec-20201231_pre.xml EX-101.PRE 18004
Mailing Address 151 OYSTER POINT BLVD., SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD., SUITE 300 SOUTH SAN FRANCISCO CA 94080 415-231-5660
Alector, Inc. (Filer) CIK: 0001653087 (see all company filings)

IRS No.: 462702363 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-38792 | Film No.: 21781681
SIC: 2836 Biological Products, (No Diagnostic Substances)